Diagnostic platform CARMEN combines microfluidics with CRISPR-based detection technology SHERLOCK, and could one day be used for public health efforts.
MIT scientist for over 50 years was a cherished mentor who published nearly 400 papers on topics from laser science to non-invasive biomedical diagnosis.